Fierce Biotech12d
Sanofi pays $600M upfront for Dren Bio's bispecific in latest immunology play
In the latest move to cement its “immunology powerhouse” status, Sanofi is handing ove | The CD20-directed antibody, dubbed ...
Nature3y
CD8-positive T cells articles from across Nature Portfolio
with the latter inhibiting CD8 T cell function via TP53 UFMylation elicited by exosomal SerpinB9 from multiple myeloma. VDAC2 deficiency elicits uncontrolled IFNγ-induced BAK activation and ...
Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing ...